“rna” Archives

in
Entry Author Date Location
With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up 11/08/17 Boston
CRISPR Pioneer Zhang Details New Editing System Downstream From DNA 10/25/17 Boston
From UCSF, New Sequencer Reveals Cancer Blueprints, Cell By Cell 10/17/17 San Francisco
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
Eyeing a Comeback, Arrowhead Bets on New RNAi Delivery Tool 09/19/17 Wisconsin
GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up 08/11/17 San Diego
CRISPR Pioneer Zhang Preaches Extra Caution In Human Gene Editing 07/31/17 Boston
Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups 07/26/17 San Francisco
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall 06/12/17 San Diego
“Our Son’s Fate”: Parents Fighting for Kids’ Spine Drug Eye New Data 04/20/17 Boston
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
With Government Backing, Moderna Joins the Zika Vaccine Chase 09/07/16 Boston
Pfizer Invests in Wave, Inks Metabolic-Focused Drug Development Deal 05/05/16 Boston
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
WaVe Joins the Crossover Party With $66M Series B for RNA Drugs 08/18/15 Boston
Accelerate LI, Eyeing New Seed Fund, Debuts Ninth Grad: Envisagenics 07/29/15 New York
Waksal’s Kadmon Spins Out Gene Therapy Group But Keeps Details Close 05/01/15 New York
Austin Biotech Mirna Therapeutics Nabs Nearly $42M in Series D Funding 04/30/15 Texas
Resistance Is Futile: Why That’s A Good Thing In Biomedicine 02/09/15 Seattle
WaVe Gets $18M to Solve RNA’s “Underappreciated” Chemistry Problem 02/02/15 Boston
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Stealth Mode is the New Sweet Spot for Some Biotechs 07/14/14 National
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
Page 1 of 2 next page »